COVID-19 saliva screening test market forecast (2026–2030)
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Are The Market Size Estimates For The COVID-19 Saliva Screening Test Potential Market In 2026 And 2030?
The potential market size for covid-19 saliva screening tests has demonstrated robust growth over recent years. This market is projected to expand from $4.28 billion in 2025 to $4.69 billion in 2026, at a compound annual growth rate (CAGR) of 9.5%. The historical growth in this sector is attributable to the discomfort associated with swab-based testing, the imperative for frequent screening, concerns regarding infection control, the demand for scalable testing solutions, and responses to public health emergencies.
The potential market size for covid-19 saliva screening tests is expected to demonstrate significant expansion in the coming years. It is projected to achieve a value of $6.46 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.4%. The impetus for this growth during the forecast period can be attributed to future pandemic preparedness strategies, the increasing prevalence of decentralized diagnostics, the expansion of workplace testing, the demand for cost-effective mass screening, and continuous innovation in saliva-based technologies. Prominent trends anticipated within the forecast period include a general shift towards non-invasive testing methods, the broadening of large-scale community screening efforts, a rising acceptance of self-collection testing, its deployment in high-traffic public locations, and its integration with comprehensive workplace safety programs.
Access Your Free Sample Report For In-Depth Market Analysis:
What Major Factors Are Driving The COVID-19 Saliva Screening Test Potential Market Forward?
The rise in healthcare expenditure is anticipated to advance the growth of the COVID-19 saliva screening test potential market moving forward. Healthcare expenditure refers to the total funds dedicated to health-related products and services, including prescription drugs, hospital stays, doctor visits, medical equipment, and public health campaigns. This expenditure is escalating due to various elements like minimally invasive surgeries, cutting-edge diagnostic tools, increased research and development for new drugs, utilization of healthcare services, and specialty medications. Greater healthcare spending can offer the essential resources and backing to capitalize on the full capabilities of COVID-19 saliva screening tests, leading to more efficient pandemic management and enhanced public health outcomes. For instance, in December 2024, as per the U.S. Centers for Medicare & Medicaid Services (CMS), a US-based federal health agency, national health-care spending saw an increase of 7.5%, amounting to US $4.9 trillion, when compared to the prior year. Thus, the increasing healthcare expenditure is fueling the growth of the COVID-19 saliva screening test potential market.
Which Segments Define The COVID-19 Saliva Screening Test Potential Market Segment Structure?
The covid-19 saliva screening test potential market covered in this report is segmented –
1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations
2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9
3) By Mode Of Testing: Centralized Testing, Decentralized Testing
Subsegments:
1) By Travel Stations: Airports, Train Stations, Bus Stations, Seaports
2) By Sports Arenas: Stadiums, Arenas, Event Halls
3) By Entertainment Venues: Theaters, Concert Halls, Amusement Parks, Nightclubs
4) By Corporate Campus Environments: Offices, Corporate Campuses, Business Parks
5) By Universities And Colleges: Higher Education Campuses, Research Institutions, Student Housing Areas
6) By Factories: Manufacturing Plants, Production Facilities, Industrial Sites
7) By Other Locations: Healthcare Facilities, Government Buildings, Public Transportation Hubs, Shopping Centers
Which Trends Are Impacting The Progress Of The COVID-19 Saliva Screening Test Potential Market?
Major companies operating in the COVID-19 saliva screening test market are focused on developing innovative technologies, such as data-sharing platforms, to enhance real-time communication and collaboration among healthcare providers, laboratories, and public health authorities. This ultimately improves the efficiency and accuracy of testing, tracking, and response efforts during the pandemic. Data-sharing platforms are digital systems that facilitate the secure exchange of data among various stakeholders like healthcare providers, researchers, and organizations, enabling collaboration and information access to improve decision-making, efficiency, and outcomes across sectors. For instance, in May 2024, Mount Sinai Health System, a US-based healthcare network, launched the Center for Healthcare Readiness. This Center concentrates on improving strategies for public health emergency response, ensuring healthcare systems can effectively handle large-scale crises such as pandemics or natural disasters. It aims to enhance the capacity of the Mount Sinai Health System and collaborate with local, regional, and federal partners to develop comprehensive preparedness plans.
Who Are The Established Players Within The COVID-19 Saliva Screening Test Potential Market?
Major companies operating in the covid-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene
Get The Full COVID-19 Saliva Screening Test Potential Market Report:
Which Region Holds The Highest Market Share In The COVID-19 Saliva Screening Test Potential Market?
North America was the largest region in the COVID-19 saliva screening test potential market in 2025. The regions covered in the covid-19 saliva screening test potential market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized COVID-19 Saliva Screening Test Potential Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global COVID-19 Saliva Screening Test Potential Market 2026, By The Business Research Company
Artificial Saliva Market Report 2026
https://www.thebusinessresearchcompany.com/report/artificial-saliva-global-market-report
Covid 19 Antigen Test Market Report 2026
https://www.thebusinessresearchcompany.com/report/covid-19-antigen-test-global-market-report
Covid 19 Rapid Test Kits Market 2026
https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
